1 |
Yun CL, Zierath JR. 2006. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116: 1776- 1783.
DOI
ScienceOn
|
2 |
Carling D. 2004. The AMP-activated protein kinase cascade− a unifying system for energy control. Trends Biochem Sci 29: 18-24.
DOI
ScienceOn
|
3 |
Hardie DG, Hawley SA, Scott JW. 2006. AMP-activated protein kinase − development of the energy sensor concept. J Physiol 574: 7-15.
DOI
ScienceOn
|
4 |
Witczak CA, Sharoff CG, Goodyear LJ. 2008. AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 65: 3737-3755.
DOI
|
5 |
Habinowski SA, Witters LA. 2001. The effect of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 286: 852-858.
DOI
ScienceOn
|
6 |
Dagon Y, Avraham Y, Berry EM. 2006. AMPK activation regulates apoptosis, adipogenesis, and lipolysis by elF2alpha in adipocytes. Biochem Biophys Res Commun 340: 43-47.
DOI
ScienceOn
|
7 |
Stralsjo L, Alklint C, Olsson ME, Sjoholm I. 2003. Total folate content and retention in rosehips (Rosa ssp.) after drying. J Agric Food Chem 51: 4291-4295.
DOI
ScienceOn
|
8 |
Daels-Rakotoarison DA, Gressier B, Trotin F, Brunet C, Luyckx M, Dine T, Bailleul F, Cazin M, Cazin JC. 2002. Effects of Rosa canina fruit extract on neutrophil respiratory burst. Phytother Res 16: 157-161.
DOI
ScienceOn
|
9 |
Hodisan T, Culea M, Cimpoiu C, Cot A. 1998. Separation, identification and quantitative determination of free amino acids from plant extracts. J Pharm Biomed Anal 18: 319-323.
DOI
ScienceOn
|
10 |
Crowley VE. 2008. Overview of human obesity and central mechanisms regulating energy homeostasis. Ann Clin Biochem 45: 245-255.
DOI
ScienceOn
|
11 |
Ninomiya K, Matsuda H, Kubo M, Morikawa T, Nishida N, Yoshikawa M. 2007. Potent anti-obese principle from Rosa canina: structural requirements and mode of action of transtiliroside. Bioorg Med Chem Lett 17: 3059-3064.
DOI
ScienceOn
|
12 |
Goto T, Teraminami A, Lee JY, Ohyama K, Funakoshi K, Kim YI, Hirai S, Uemura T, Yu R, Takahashi N, Kawada T. 2012. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice. J Nutr Biochem 23: 768-776.
DOI
ScienceOn
|
13 |
Qin N, Li CB, Jin MN, Shi LH, Duan HQ, Niu WY. 2011. Synthesis and biological activity of novel tiliroside derivants. Eur J Med Chem 46: 5189-5195.
DOI
ScienceOn
|
14 |
Andersson U, Henriksson E, Ström K, Alenfall J, Göransson O, Holm C. 2011. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program. Am J Physiol Endocrinol Metab 300: E111-E121.
DOI
ScienceOn
|
15 |
Matsuda H, Ninomiya K, Shimoda H, Yoshikawa M. 2002. Hepatoprotective principles from the flowers of Tilia argentea (linden): structure requirements of tiliroside and mechanisms of action. Bioorg Med Chem 10: 707-712.
DOI
ScienceOn
|
16 |
Tsukamoto S, Tomise K, Aburatani M, Onuki H, Hirota H, Ishiharajima E, Ohta T. 2004. Isolation of cytochrome P450 inhibitors from strawberry fruit, Fragaria ananassa. J Nat Prod 67: 1839-1841.
DOI
ScienceOn
|
17 |
Rao YK, Geethangili M, Fang SH, Tzeng YM. 2007. Antioxidant and cytotoxic activities of naturally occurring phenolic and related compounds: a comparative study. Food Chem Toxicol 45: 1770-1776.
DOI
ScienceOn
|
18 |
Lu YH, Chen J, Wei DZ, Wang ZT, Tao XY. 2009. Tyrosinase inhibitory effect and inhibitory mechanism of tiliroside from raspberry. J Enzyme Inhib Med Chem 24: 1154-1160.
DOI
ScienceOn
|
19 |
Sala A, Recio MC, Schinella GR, Máñez S, Giner RM, Cerdá- Nicolás M, Rosí JL. 2003. Assessment of the anti-inflammatory activity and free radical scavenger activity of tiliroside. Eur J Pharmacol 461: 53-61.
DOI
ScienceOn
|
20 |
Tomczyk M, Drozdowska D, Bielawska A, Bielawski K, Gudej J. 2008. Human DNA topoisomerase inhibitors from Potentilla argentea and their cytotoxic effect against MCF-7. Pharmazie 63: 389-393.
|
21 |
Goto T, Horita M, Nagai H, Nagatomo A, Nishida N, Matsuura Y, Nagaoka S. 2012. Tiliroside, a glycosidic flavonoid, inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract. Mol Nutr Food Res 56: 435-445.
DOI
ScienceOn
|
22 |
Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509.
|
23 |
Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
DOI
ScienceOn
|
24 |
Moreno M, Lombardi A, Silvestri E, Senese R, Cioffi F, Goglia F, Lanni A, Lange P. 2010. PPARs: Nuclear receptors controlled by, and controlling, nutrient handling through nuclear and cytosolic signaling. PPAR Res 2010: doi:10.1155/2010/435689
DOI
|
25 |
Wu Z, Xie Y, Bucher NL, Farmer SR. 1995. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev 9: 2350-2363.
DOI
ScienceOn
|
26 |
Grey A, Bolland M, Gamble G, Wattie D, Horne A, Davidson J, Reid IR. 2007. The peroxisome proliferator-activated receptor-g agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women. A randomized, controlled trial. J Clin Endocrinol Metab 92: 1305-1310.
DOI
ScienceOn
|
27 |
He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans R. 2003. Adipose-specific peroxisome proliferator-activated receptor knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 100: 15712-15717.
DOI
ScienceOn
|
28 |
Abbas A, Blandon J, Rude J, Elfar A, Mukherjee D. 2012. PPAR- agonist in treatment of diabetes: cardiovascular safety considerations. Cardiovasc Hematol Agents Med Chem 10: 124-134.
DOI
ScienceOn
|
29 |
Nissen SE, Wolski K. 2007. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457-2471.
DOI
ScienceOn
|
30 |
Rayalam S, Della-Fera MA, Yang JY, Park HJ, Ambati S, Baile CA. 2007. Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J Nutr 137: 2668-2673.
DOI
|
31 |
Ejaz A, Wu D, Kwan P, Meydani M. 2009. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139: 919-925.
DOI
ScienceOn
|
32 |
Roh C, Park MK, Shin HJ, Jung U, Kim JK. 2012. Buddleja officinalis Maximowicz extract inhibits lipid accumulation on adipocyte differentiation in 3T3-L1 cells and high-fat mice. Molecules 17: 8687-8695.
DOI
ScienceOn
|
33 |
Gu W, Kim KA, Kim DH. 2013. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol Pharm Bull 36: 102-107.
|
34 |
Huang C, Zhang Y, Gong Z, Sheng X, Li Z, Zhang W, Qin Y. 2006. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR pathway. Biochem Biophys Res Commun 348: 571-578.
DOI
ScienceOn
|
35 |
Park UH, Jeong JC, Jang JS, Sung MR, Youn H, Lee SJ, Kim EJ, Um SJ. 2012. Negative regulation of adipogenesis by kaempferol, a component of Rhizoma Polygonati falcatum in 3T3-L1 cells. Biol Pharm Bull 35: 1525-1533.
DOI
|